Cargando…

New Therapeutic Options for Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), one of the most common lethal diseases in the world, has a 5-year survival rate of only 7%. Hepatocellular carcinoma has no symptoms in the early stage but obvious symptoms in the late stage, leading to delayed diagnosis and reduced treatment efficacy. In recent years...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yu-Shui, Liu, Ji-Bin, Wu, Ting-Miao, Fu, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791453/
https://www.ncbi.nlm.nih.gov/pubmed/32799550
http://dx.doi.org/10.1177/1073274820945975